Harel Deutsch, M.D., Joins Baptist Health Miami Neuroscience Institute as Director of Spine Surgery

• by

• August 24, 2026

FDA Approves New Iohexol Vials

The approval includes additional 300 mg iodine/mL and 350 mg iodine/mL vial presentations.

• by Kathryn Wighton

• July 17, 2026

• 2 min

Spinal metastases in geriatric patients: a retrospective single-center comparison of mortality and surgical outcomes following neurosurgical treatment

• by Saif-Eldin Abedellatif, Marija Janjic, Logman Khalafov, Harun Asoglu, Juliane Dittmer, Haitham Alenezi, Ivan Maiseyeu, Mohammed Jaber, Muriel Heimann, Tim Lampmann, Matthias Schneider, Hartmut Vatter, Motaz Hamed, Mohammed Banat

• July 16, 2026

FDA Clears Olastrocel Trial Expansion

Additional patients with ongoing opioid use are being enrolled as Creative Medical prepares for potential Phase 3 discussions with the FDA.

• by Kathryn Wighton

• June 22, 2026

• 3 min